Evidence map›Paper›PMID 27737726›Full record

ArticleCell transplantation2017

Neural Stem Cell-Conditioned Medium Suppresses Inflammation and Promotes Spinal Cord Injury Recovery.

Zhijian Cheng, Dale B Bosco, Li Sun, Xiaoming Chen, Yunsheng Xu, Wenjiao Tai, Ruth Didier, Jinhua Li, Jianqing Fan, Xijing He and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell transplantation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Rewiring the Spine-Cutting-Edge Stem Cell Therapies for Spinal Cord Repair.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Cell transplantation to repair the injured spinal cord.International review of neurobiology · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Zhijian Cheng
Dale B Bosco
Li Sun
Xiaoming Chen
Yunsheng Xu
Wenjiao Tai
Ruth Didier
Jinhua Li
Jianqing Fan
Xijing He
Yi Ren
Florida State University · USWenzhou Medical University · CNSecond Affiliated Hospital of Xi'an Jiaotong University · CNFirst Affiliated Hospital of Wenzhou Medical University · CNMonash University · AUPrinceton University · US

Funding

Statistical Methods for Ultrahigh-dimensional Biomedical DataR01GM072611 · NIGMS · PRINCETON UNIVERSITY · PI CATTANEO, MATIAS DAMIAN · 2006 to 2021
$4.2M
Quantitative Methods for Genome-wide Analysis of Macrophage Activation by ESCsR01GM100474 · NIGMS · PRINCETON UNIVERSITY · PI FAN, JIANQING · 2011 to 2014
$1.5M
NIGMS NIH HHS R01 GM072611NIGMS NIH HHS R01 GM100474
6 · The paper itself

Abstract

Spinal cord injury (SCI) causes functional impairment as a result of the initial injury followed by secondary injury mechanism. SCI provokes an inflammatory response that causes secondary tissue damage and neurodegeneration. While the use of neural stem cell (NSC) engraftment to mitigate secondary injury has been of interest to many researchers, it still faces several limitations. As such, we investigated if NSC-conditioned medium (NSC-M) possesses therapeutic potential for the treatment of SCI. It has been proposed that many of the beneficial effects attributed to stem cell therapies are due to secreted factors. Utilizing primary cell culture and murine models of SCI, we determined that systemic treatment with NSC-M was able to significantly improve motor function and lesion healing. In addition, NSC-M demonstrated significant anti-inflammatory potential in vitro and in vivo, reducing inflammatory cytokine expression in both activated macrophages and injured spinal cord tissues. NSC-M was also able to reduce the expression of inducible nitric oxide synthase (iNOS) within the spleen of injured animals, indicating an ability to reduce systemic inflammation. Thus, we believe that NSC-M offers a possible alternative to direct stem cell engraftment for the treatment of SCI.

Indexed as

AnimalsCells, CulturedCulture Media, ConditionedEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryInflammationMacrophagesMiceMice, Inbred C57BLNeural Stem CellsNitric Oxide Synthase Type IIPhagocytosisReal-Time Polymerase Chain ReactionSpinal Cord InjuriesCulture Media, ConditionedNitric Oxide Synthase Type II

Identifiers

PMID27737726
PMCPMC5657700
OpenAlexW2571820947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.